
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults
Giuseppe Cicala, María Antonietta Barbieri, Edoardo Spina, et al.
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 3, pp. 219-234
Closed Access | Times Cited: 72
Giuseppe Cicala, María Antonietta Barbieri, Edoardo Spina, et al.
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 3, pp. 219-234
Closed Access | Times Cited: 72
Showing 1-25 of 72 citing articles:
A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology
José de León, Can‐Jun Ruan, Georgios Schoretsanitis, et al.
Psychotherapy and Psychosomatics (2020) Vol. 89, Iss. 4, pp. 200-214
Open Access | Times Cited: 132
José de León, Can‐Jun Ruan, Georgios Schoretsanitis, et al.
Psychotherapy and Psychosomatics (2020) Vol. 89, Iss. 4, pp. 200-214
Open Access | Times Cited: 132
Data From the World Health Organization’s Pharmacovigilance Database Supports the Prominent Role of Pneumonia in Mortality Associated With Clozapine Adverse Drug Reactions
José de León, Emílio J. Sanz, Carlos De las Cuevas
Schizophrenia Bulletin (2019) Vol. 46, Iss. 1, pp. 1-3
Open Access | Times Cited: 106
José de León, Emílio J. Sanz, Carlos De las Cuevas
Schizophrenia Bulletin (2019) Vol. 46, Iss. 1, pp. 1-3
Open Access | Times Cited: 106
A comprehensive review of the clinical utility of and a combined analysis of the clozapine/norclozapine ratio in therapeutic drug monitoring for adult patients
Georgios Schoretsanitis, John M. Kane, Can‐Jun Ruan, et al.
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 7, pp. 603-621
Closed Access | Times Cited: 85
Georgios Schoretsanitis, John M. Kane, Can‐Jun Ruan, et al.
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 7, pp. 603-621
Closed Access | Times Cited: 85
Clozapine is strongly associated with the risk of pneumonia and inflammation
José de León, Can‐Jun Ruan, Hélène Verdoux, et al.
General Psychiatry (2020) Vol. 33, Iss. 2, pp. e100183-e100183
Open Access | Times Cited: 84
José de León, Can‐Jun Ruan, Hélène Verdoux, et al.
General Psychiatry (2020) Vol. 33, Iss. 2, pp. e100183-e100183
Open Access | Times Cited: 84
Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second‐generation antipsychotics
José de León, Emílio J. Sanz, G. Niklas Norén, et al.
World Psychiatry (2020) Vol. 19, Iss. 1, pp. 120-121
Open Access | Times Cited: 76
José de León, Emílio J. Sanz, G. Niklas Norén, et al.
World Psychiatry (2020) Vol. 19, Iss. 1, pp. 120-121
Open Access | Times Cited: 76
Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review
Hélène Verdoux, Clélia Quilès, José de León
Schizophrenia Research (2019) Vol. 211, pp. 1-9
Open Access | Times Cited: 71
Hélène Verdoux, Clélia Quilès, José de León
Schizophrenia Research (2019) Vol. 211, pp. 1-9
Open Access | Times Cited: 71
Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics
José de León
Neuropharmacology (2019) Vol. 168, pp. 107656-107656
Closed Access | Times Cited: 67
José de León
Neuropharmacology (2019) Vol. 168, pp. 107656-107656
Closed Access | Times Cited: 67
Clozapine in the treatment of refractory schizophrenia: a practical guide for healthcare professionals
Robert J. Flanagan, John Lally, Siobhan Gee, et al.
British Medical Bulletin (2020) Vol. 135, Iss. 1, pp. 73-89
Open Access | Times Cited: 53
Robert J. Flanagan, John Lally, Siobhan Gee, et al.
British Medical Bulletin (2020) Vol. 135, Iss. 1, pp. 73-89
Open Access | Times Cited: 53
An update on the complex relationship between clozapine and pneumonia
Georgios Schoretsanitis, Can‐Jun Ruan, Christopher Rohde, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 2, pp. 145-149
Open Access | Times Cited: 42
Georgios Schoretsanitis, Can‐Jun Ruan, Christopher Rohde, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 2, pp. 145-149
Open Access | Times Cited: 42
Escaping the Long Shadow Cast by Agranulocytosis
José de León, Manuel Arrojo, Hélène Verdoux, et al.
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 3, pp. 239-245
Closed Access | Times Cited: 19
José de León, Manuel Arrojo, Hélène Verdoux, et al.
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 3, pp. 239-245
Closed Access | Times Cited: 19
Rethinking Clozapine: Lights and Shadows of a Revolutionary Drug
Liliana Dell’Osso, Chiara Bonelli, Benedetta Nardi, et al.
Brain Sciences (2024) Vol. 14, Iss. 1, pp. 103-103
Open Access | Times Cited: 7
Liliana Dell’Osso, Chiara Bonelli, Benedetta Nardi, et al.
Brain Sciences (2024) Vol. 14, Iss. 1, pp. 103-103
Open Access | Times Cited: 7
Polypharmacy and Its Association with Dysphagia and Malnutrition among Stroke Patients with Sarcopenia
Ayaka Matsumoto, Yoshihiro Yoshimura, Fumihiko Nagano, et al.
Nutrients (2022) Vol. 14, Iss. 20, pp. 4251-4251
Open Access | Times Cited: 26
Ayaka Matsumoto, Yoshihiro Yoshimura, Fumihiko Nagano, et al.
Nutrients (2022) Vol. 14, Iss. 20, pp. 4251-4251
Open Access | Times Cited: 26
Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review
Sarah Smessaert, Johan Detraux, Siska Desplenter, et al.
CNS Drugs (2024) Vol. 38, Iss. 2, pp. 105-123
Closed Access | Times Cited: 5
Sarah Smessaert, Johan Detraux, Siska Desplenter, et al.
CNS Drugs (2024) Vol. 38, Iss. 2, pp. 105-123
Closed Access | Times Cited: 5
Clozapine for persons with neurodevelopmental disorders: a systematic review and expert recommendations for clinical practice
Hélène Verdoux, Clélia Quilès, José de León
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 10, pp. 923-933
Closed Access | Times Cited: 5
Hélène Verdoux, Clélia Quilès, José de León
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 10, pp. 923-933
Closed Access | Times Cited: 5
Functional dysphagia: Developing a framework for assessment and treatment
Anna Miles, Janet Baker, Suzanne Barker‐Collo, et al.
International Journal of Speech-Language Pathology (2025), pp. 1-16
Open Access
Anna Miles, Janet Baker, Suzanne Barker‐Collo, et al.
International Journal of Speech-Language Pathology (2025), pp. 1-16
Open Access
Dysphagia and geriatric syndromes in older patients admitted to an intermediate care unit: prospective observational study
Francesca Dini, Stefania Mancini, Angela Girelli, et al.
Aging Clinical and Experimental Research (2025) Vol. 37, Iss. 1
Open Access
Francesca Dini, Stefania Mancini, Angela Girelli, et al.
Aging Clinical and Experimental Research (2025) Vol. 37, Iss. 1
Open Access
Subjectively Low Oral Function Is Associated With Physical Frailty and Polypharmacy in Community‐Dwelling Older Adults
Aya Hirata, Masahiro Ishizaka, Akihiro Yakabi, et al.
Gerodontology (2025)
Closed Access
Aya Hirata, Masahiro Ishizaka, Akihiro Yakabi, et al.
Gerodontology (2025)
Closed Access
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Revealing the reporting disparity: VigiBase highlights underreporting of clozapine in other Western European countries compared to the UK
Carlos De las Cuevas, Emílio J. Sanz, Jason A. Gross, et al.
Schizophrenia Research (2023) Vol. 268, pp. 175-188
Open Access | Times Cited: 12
Carlos De las Cuevas, Emílio J. Sanz, Jason A. Gross, et al.
Schizophrenia Research (2023) Vol. 268, pp. 175-188
Open Access | Times Cited: 12
Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital
Nuree Kang, Se Hyun Kim, Jayoun Kim, et al.
Schizophrenia Research (2023) Vol. 268, pp. 107-113
Closed Access | Times Cited: 11
Nuree Kang, Se Hyun Kim, Jayoun Kim, et al.
Schizophrenia Research (2023) Vol. 268, pp. 107-113
Closed Access | Times Cited: 11
Investigating in VigiBase® over 6000 cases of pneumonia in clozapine-treated patients in the context of the literature: focus on high lethality and the association with aspiration pneumonia
José de León, Can‐Jun Ruan, Georgios Schoretsanitis, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 8, pp. 857-871
Closed Access | Times Cited: 4
José de León, Can‐Jun Ruan, Georgios Schoretsanitis, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 8, pp. 857-871
Closed Access | Times Cited: 4
Effects of Intravenous Hydroxyzine Versus Haloperidol Monotherapy for Delirium
Kaoruhiko Kubo, Moe Takehara, Mayuko Hirata, et al.
The Journal of Clinical Psychiatry (2025) Vol. 86, Iss. 1
Closed Access
Kaoruhiko Kubo, Moe Takehara, Mayuko Hirata, et al.
The Journal of Clinical Psychiatry (2025) Vol. 86, Iss. 1
Closed Access
27 Special Kinds of Dysphagia
Antoinette am Zehnhoff‐Dinnesen, Carl-Albert Bader, Liesbeth ten Cate, et al.
European manual of medicine (2025), pp. 327-404
Closed Access
Antoinette am Zehnhoff‐Dinnesen, Carl-Albert Bader, Liesbeth ten Cate, et al.
European manual of medicine (2025), pp. 327-404
Closed Access
Pneumonia risk: approximately one‐third is due to clozapine and two‐thirds is due to treatment‐resistant schizophrenia
Alejandro Villasante‐Tezanos, Christopher Rohde, Jimmi Nielsen, et al.
Acta Psychiatrica Scandinavica (2020) Vol. 142, Iss. 1, pp. 66-67
Closed Access | Times Cited: 32
Alejandro Villasante‐Tezanos, Christopher Rohde, Jimmi Nielsen, et al.
Acta Psychiatrica Scandinavica (2020) Vol. 142, Iss. 1, pp. 66-67
Closed Access | Times Cited: 32